A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Recruiting · NCT06083207 · Registry updated 2024-12-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 / Phase 2 | 2024-12-13 | NCT06083207 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innovent Biologics (Suzhou) Co. Ltd. | 82 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Austin Hospital | Heidelberg | Australia | 37 |
| Jiangsu Province Hospital | Nanjing | China | 89 |
| Jiangxi Cancer Hospital | Nanchang | China | 48 |
| Peking Union Medical College Hospital | Beijing | China | 201 |
| St Vincent's Hospital | Melbourne | Australia | 8 |
| The Affiliated Hospital of Xuzhou Medical University | Xuzhou | China | 15 |
| The First Affiliated Hospital of Guangxi Medical University | Nanning | China | 66 |
| The First Affiliated Hospital of Soochow University | Suzhou | China | 101 |
| The First Affiliated Hospital of Xi'an Jiaotong University | Xian | China | 2 |
| Tianjin Medical University General Hospital | Tianjin | China | 3 |
| Tongji Medical College of HUST Tongji Hospital | Wuhan | China | 1 |
| Wollongong Private Hospital | Wollongong | Australia | 2 |
| ZhongShan Hospital FuDan University | Shanghai | China | 1 |